Biora Therapeutics (4ZU) Financial Statements

0 Followers

Biora Therapeutics Financial Overview

Biora Therapeutics's market cap is currently €388.00. The company's EPS TTM is €; its P/E ratio is ―; Biora Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 4.00K	$ 305.00K	$ 1.25M	$ 74.31M	$ 143.99M
Gross Profit	$ 4.00K	$ 305.00K	$ 1.25M	$ -19.12M	$ 43.49M
Operating Income	$ -67.14M	$ -61.78M	$ -117.84M	$ -107.62M	$ -140.12M
EBITDA	$ -114.05M	$ -37.35M	$ -164.57M	$ -106.18M	$ -135.44M
Net Income	$ -124.11M	$ -38.16M	$ -178.52M	$ -192.53M	$ -148.04M
Balance Sheet
Cash & Short-Term Investments	$ 15.21M	$ 30.49M	$ 88.40M	$ 92.08M	$ 33.04M
Total Assets	$ 31.21M	$ 53.52M	$ 108.84M	$ 154.44M	$ 101.73M
Total Debt	$ 47.43M	$ 129.31M	$ 126.40M	$ 160.54M	$ 73.37M
Net Debt	$ 32.22M	$ 98.82M	$ 38.01M	$ 70.23M	$ 40.33M
Total Liabilities	$ 132.64M	$ 155.81M	$ 193.81M	$ 261.43M	$ 185.60M
Stockholders' Equity	$ -101.42M	$ -102.29M	$ -84.98M	$ -106.99M	$ -83.87M
Cash Flow
Free Cash Flow	$ -48.60M	$ -65.21M	$ -168.34M	$ -170.69M	$ -109.85M
Operating Cash Flow	$ -48.50M	$ -64.42M	$ -167.49M	$ -165.74M	$ -106.12M
Investing Cash Flow	$ 2.44M	$ -792.00K	$ -1.24M	$ -4.94M	$ 16.52M
Financing Cash Flow	$ 30.78M	$ 7.30M	$ 165.05M	$ 229.72M	$ 73.64M

Currency in USD

Biora Therapeutics Earnings and Revenue History

Income Statement >

Biora Therapeutics Debt to Assets

Balance Sheet >

Biora Therapeutics Cash Flow

Cash Flow >

Biora Therapeutics Forecast EPS vs Actual EPS

Earnings >